Company intelligence / Profile preview

Cannabix Technologies

Burnaby, British Columbia, Canada

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Cannabix Technologies has developed commercial-stage, non-invasive breathalyzer devices for the detection of tetrahydrocannabinol (THC) and alcohol, with products such as the Cannabix Marijuana Breathalyzer and Breath Logix approved for workplace and law enforcement use[1][3][4].

Therapeutic areas: NeurologyPsychiatry
Modalities: Device
Industry: Metabolite Diagnostics

Partnerships

AlcoPro Inc.Omega Laboratories Inc.

Beyond the preview

Go deeper on Cannabix Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cannabix Technologies.

Explore the full profile